Overview

Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of repeated intravitreal (ITV) administration of VEGF Trap.
Phase:
Phase 1
Details
Lead Sponsor:
Regeneron Pharmaceuticals
Treatments:
Aflibercept